Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes

<p>Table S1. Genes included in the targeted DNA panel sequencing. Table S2. Differences in clinical characteristics by molecular subtype. Table S3. Distributions of mutation status in PBRM1 and SETD2 by molecular subtype in RNASeq and Nanostring datasets. Table S4. Differentially expressed gen...

Tallennettuna:

Bibliografiset tiedot
Päätekijä:	Jiwei Bai (15051797) (author)
Muut tekijät:	Jianxin Shi (15051800) (author), Yazhuo Zhang (15051803) (author), Chuzhong Li (15051806) (author), Yujia Xiong (15051809) (author), Hela Koka (15051812) (author), Difei Wang (15051815) (author), Tongwu Zhang (15051818) (author), Lei Song (15051821) (author), Wen Luo (15051824) (author), Bin Zhu (15051827) (author), Belynda Hicks (15051830) (author), Amy Hutchinson (15051833) (author), Erin Kirk (15051836) (author), Melissa A. Troester (15051839) (author), Mingxuan Li (15051842) (author), Yutao Shen (15051845) (author), Tianshun Ma (15051848) (author), Junmei Wang (15051851) (author), Xing Liu (15051854) (author), Shuai Wang (15051857) (author), Songbai Gui (15051860) (author), Mary L. McMaster (15051863) (author), Stephen J. Chanock (15051866) (author), Dilys M. Parry (15051869) (author), Alisa M. Goldstein (15051872) (author), Xiaohong R. Yang (15051875) (author)
Julkaistu:	2025
Aiheet:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Genome Biology Comparative transcriptomics Rare Cancers Translational Research
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Tekijä: Jiwei Bai (15051797)
Julkaistu: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Tekijä: Jiwei Bai (15051797)
Julkaistu: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Tekijä: Jiwei Bai (15051797)
Julkaistu: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Tekijä: Jiwei Bai (15051797)
Julkaistu: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Tekijä: Jiwei Bai (15051797)
Julkaistu: (2025)

Table S2 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
Tekijä: Junfeng Xu (16437141)
Julkaistu: (2025)

Table S3 from MEN1 Degradation Induced by Neddylation and the CUL4B–DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression
Tekijä: Junfeng Xu (16437141)
Julkaistu: (2025)

العمل بالأكثر والغالب عند الأصوليين: دراسة تطبيقية
Tekijä: Al-mutiri, Aloush Khaled
Julkaistu: (2022)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
Tekijä: Zhongyi Zhang (219440)
Julkaistu: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
Tekijä: Zhongyi Zhang (219440)
Julkaistu: (2025)

Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
Tekijä: Alyssa C. Flint (16676029)
Julkaistu: (2025)

Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
Tekijä: Alyssa C. Flint (16676029)
Julkaistu: (2025)

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
Tekijä: Gwo Yaw Ho (14961416)
Julkaistu: (2025)

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Tekijä: Evangeline R. Jackson (15558808)
Julkaistu: (2025)

Spreadsheet index of named bookbinders in the Sotheby's auction catalogues for the sales of the Major John Roland Abbey collection, sold between 1965 and 1989
Tekijä: John Hodgson (22668215)
Julkaistu: (2025)

Supplementary Data from β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Tekijä: Dipika R. Mohan (15011204)
Julkaistu: (2025)

Supplementary Tables from Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer
Tekijä: Yemin Wang (17315078)
Julkaistu: (2025)

Video 1_Imaging-driven diagnosis of retroperitoneal psoas major alveolar soft part sarcoma: a case report.mp4
Tekijä: Shasha Wei (1555588)
Julkaistu: (2025)

Supplementary Table S10 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Tekijä: Anfal Alsadhan (15907475)
Julkaistu: (2025)

Supplementary Table S4 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Tekijä: Anfal Alsadhan (15907475)
Julkaistu: (2025)

Supplementary Table S5 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Tekijä: Anfal Alsadhan (15907475)
Julkaistu: (2025)

Supplementary Table S6 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Tekijä: Anfal Alsadhan (15907475)
Julkaistu: (2025)

Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Tekijä: Anfal Alsadhan (15907475)
Julkaistu: (2025)

Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Tekijä: Anfal Alsadhan (15907475)
Julkaistu: (2025)

Supplementary Table S9 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Tekijä: Anfal Alsadhan (15907475)
Julkaistu: (2025)

Additional file 1 of Combined metabolome and transcriptome profiling provides insights into dynamic molecular control of lemon (Citrus Limon L.) peel development
Tekijä: Hongming Liu (631933)
Julkaistu: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Tekijä: Francesca Orzan (15055579)
Julkaistu: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Tekijä: Francesca Orzan (15055579)
Julkaistu: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Tekijä: Francesca Orzan (15055579)
Julkaistu: (2025)

Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Tekijä: Justin Hwang (15925675)
Julkaistu: (2025)

Supplementary Figure 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Tekijä: Justin Hwang (15925675)
Julkaistu: (2025)

Supplementary Figure 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Tekijä: Justin Hwang (15925675)
Julkaistu: (2025)

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Tekijä: Justin Hwang (15925675)
Julkaistu: (2025)

Supplementary Table 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Tekijä: Justin Hwang (15925675)
Julkaistu: (2025)

Supplementary Table 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Tekijä: Justin Hwang (15925675)
Julkaistu: (2025)

Presentation 1_Exploring therapeutic mechanism of Fuzhenghefuzhiyang Formula in psoriasis: inflammation and metabolism regulation.pdf
Tekijä: Bin Tang (56654)
Julkaistu: (2025)

Supplementary Table S1 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
Tekijä: Nadia Mezghani (15055724)
Julkaistu: (2025)

Supplementary Table S3 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
Tekijä: Nadia Mezghani (15055724)
Julkaistu: (2025)

Supplementary Table S4 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
Tekijä: Nadia Mezghani (15055724)
Julkaistu: (2025)

Data Sheet 1_Response mechanisms of Polygonatum kingianum to temperature stress: implications for cultivation practices.pdf
Tekijä: Huali Qian (11711225)
Julkaistu: (2025)

Cannot write session to /tmp/vufind_sessions/sess_4v7uvlffje57emh33hj5u9jr6c